These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9579758)

  • 1. Women's decision-making in prenatal screening.
    Santalahti P; Hemminki E; Latikka AM; Ryynänen M
    Soc Sci Med; 1998 Apr; 46(8):1067-76. PubMed ID: 9579758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On what grounds do women participate in prenatal screening?
    Santalahti P; Aro AR; Hemminki E; Helenius H; Ryynänen M
    Prenat Diagn; 1998 Feb; 18(2):153-65. PubMed ID: 9516017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation in prenatal screening tests and intentions concerning selective termination in Finnish maternity care.
    Santalahti P; Hemminki E; Aro AR; Helenius H; Ryynänen M
    Fetal Diagn Ther; 1999; 14(2):71-9. PubMed ID: 10085503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of pregnancy following a prenatal diagnosis of Down syndrome: A qualitative study of the decision-making process of pregnant couples.
    Lou S; Carstensen K; Petersen OB; Nielsen CP; Hvidman L; Lanther MR; Vogel I
    Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1228-1236. PubMed ID: 29791717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental duties and prenatal screening: does an offer of prenatal screening lead women to believe that they are morally compelled to test?
    García E; Timmermans DR; van Leeuwen E
    Midwifery; 2012 Dec; 28(6):e837-43. PubMed ID: 22079009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B; Sinclair M; Barr O; Dobbs F; Crealey G
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
    Wald NJ; George L; Smith D; Densem JW; Petterson K
    Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum screening for Down's syndrome: some women's experiences.
    Statham H; Green J
    BMJ; 1993 Jul; 307(6897):174-6. PubMed ID: 8343748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant women's attitudes and decision-making regarding prenatal Down syndrome screening and diagnosis: scale development and validation.
    Huang WH; Shih SF; Lin CL; Liu CH
    BMC Pregnancy Childbirth; 2020 Jul; 20(1):407. PubMed ID: 32664895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.
    Crombag NM; Boeije H; Iedema-Kuiper R; Schielen PC; Visser GH; Bensing JM
    BMC Pregnancy Childbirth; 2016 May; 16(1):121. PubMed ID: 27229318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
    Spencer K; Carpenter P
    BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K; Sandall J
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results and views of women in population-wide pregnancy screening for trisomy 21 in east Finland.
    Heikkilä A; Ryynänen M; Kirkinen P; Saarikoski S
    Fetal Diagn Ther; 1997; 12(2):93-6. PubMed ID: 9218949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge of prenatal screening and psychological management of test decisions.
    Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.